Key facts
| Price (PPV) | 7,547 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | laronidase |
| Class | Other alimentary tract and metabolism products |
| ATC code | A16AB05 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Flacon de 5 ml |
| Nature | Médicament |
| Hospital price | 7,358 MAD |
| Data collected on | 9/8/2026 |
Indications
Aldurazyme est indiqué en tant que traitement enzymatique substitutif à long terme chez les patients présentant un diagnostic confirmé de mucopolysaccharidose de type I (MPS I ; déficit d’α-Liduronidase), afin de traiter les manifestations non neurologiques de la maladie.
Find an open pharmacy
On-call pharmacies near you
About Aldurazyme 100 U / ml
Aldurazyme 100 U / ml belongs to the other alimentary tract and metabolism products therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Aldurazyme 100 U / ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Aldurazyme 100 U / ml
Answers to common questions from Moroccan patients about this drug.